Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jun 28, 2026
NATURES SUNSHINE PRODUCTS INC (NATR)
A forensic read on NATURES SUNSHINE PRODUCTS INC built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Safe
Financial health
5.8
Altman Z-score
Clean
Earnings quality
3
Forensic signals
18.6
P / E (ttm)
12.3%
ROE
$370M
Market cap
NATURES SUNSHINE PRODUCTS INC earns a B (Sound & dependable) forensic quality grade, and its Altman Z-score is 5.8, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by dividend — suspended.
What the filings flag
suspendedDividend — suspended.The dividend has been SUSPENDED — $20M paid in FY2021, then $0 in FY2022. A suspension is a major signal the board is conserving cash; the prior payment history doesn't offset it.
188dInventory days.Days inventory outstanding moved from 167 to 188 FY2024→FY2025 (against cost of goods sold; inventory +15% vs +2% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.
1% of revStock-based comp load.Stock-based compensation ran 1% of revenue and 20% of free cash flow in FY2025 — about $0.31 per diluted share. Meaningful — reported free cash flow flatters the economics, since SBC is a real cost paid in shares.
Key fundamentals
Net Margin4.1%
Debt / Equity0.00x
Free Cash Flow$28.8M
Latest Revenue$480.1M
Return on Equity12.1%
Revenue Growth YoY+5.7%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on NATURES SUNSHINE PRODUCTS INC:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about NATR's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown